Skip to content

Meal Timing on Postprandial Glucose, Insulin and GLP-1 in Type 2 Diabetes

Effects of Meal Timing on Postprandial Glucose, Insulin and GLP-1 Responses After Breakfast Lunch and Dinner in Patients With Type 2 Diabetes

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01977833
Acronym
GLP-1inT2D
Enrollment
30
Registered
2013-11-07
Start date
2013-10-31
Completion date
2014-01-31
Last updated
2013-11-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 Diabetes

Keywords

BTdiet, Dtdiet, High Calorie Breakfast diet (BTdiet), High Calorie Dinner diet (DTdiet)

Brief summary

Enhanced insulin and GLP-1 postprandial response after morning meal versus evening meal, might be underlying explanation of the beneficial effect of eating breakfast with reduced dinner vs skipping breakfast on glycemic control and HbA1c in T2D patients. To test this hypothesis and clarify whether glucose, insulin and GLP-1 postprandial responses are different in the morning vs. in the afternoon, the investigators will compare in T2D subjects in random order and in two separate days: the glucose, insulin and GLP-1 postprandial responses after breakfast, lunch and dinner with 2 isocaloric meal plans or test diets, that differ in meal timing distribution The investigators hypothesize that GLP-1 and insulin response after high calorie breakfast will be higher in comparison to GLP-1 and insulin response after identical meal at evening

Detailed description

The endogenous circadian (24-h) timing system, synchronized by light/dark cycle in the master circadian clock in the suprachiasmatic nuclei and by meal timing in the peripheral clock genes; plays a significant role in regulating sleep/wake and feeding behavior, body weight as well as glucose and lipid metabolism. Circadian misalignment, involving sleep/wake and meal timing schedules 12 h out of phase from their habitual times resulted in elevated blood pressure and increased postprandial glucose and insulin levels. Animal models of circadian misalignment specially breakfast skipping are associated with alteration in the expression pattern of clock genes such as Clock, Bmal1, Cry1, and Per2 in the liver and fat cells. These changes resulted in a predisposition to obesity and type 2 diabetes (T2D). This may also explain why evening or night eating is often associated with weight gain and obesity. Breakfast skipping has been consistently associated with increased, visceral adiposity, higher BMI and waist circumference, insulin resistance, dyslipidemia and with T2D despite having less total daily caloric intake. A recent population-based studies have found that participants with an evening preferences (late chronotype) that involves breakfast skipping, have 2.5 times risk of developing T2D, even after adjustment for body mass index (BMI) (12). Breakfast skipping and greater percentage of their daily caloric intake at dinner was associated with higher fasting plasma glucose levels, and poorer glycemic control compared with earlier chronotypes even after adjusting for BMI (11,20,21). Recently was documented that in T2D patients, breakfast skipping was associated was associated with a 10.8% increase in HbA1C of its original value, even after adjusting for age, sex, race, BMI, number of diabetes complications, insulin use, depressive symptoms, perceived sleep debt, and percentage of daily caloric intake at dinner. This significant difference in HbA1C levels between breakfast skippers and breakfast eaters in patients with T2D, highlights the potential impact of the meal timing on the course of the disease. More recently the investigators documented that compared to a conventional diet, a high caloric intake in the breakfast and reduced dinner resulted in significant reduction of HbA1c in T2D individuals. The existence of diurnal variation in glucose tolerance in healthy and in subjects with T2D has been suspected for decades, with reports showing that glucose tolerance decreases progressively throughout the day with insulin sensitivity reaching a nadir in the evening. The reduction of glucose tolerance in the evening, seems to be a results from a combination of reduced glucose utilization, decreased insulin sensitivity, and inappropriately low insulin secretion and action, which highlights the importance of meal timing in glucose metabolism. It is known that insulin response to meal ingestion is more rapid in the morning than in the afternoon and specifically the early (30 or 45 min) insulin secretion after oral glucose or meal ingestion is significantly higher in the morning than in the evening. A possible explanation for the more rapid glucose clearance from the circulation in the morning is because the early insulin response is important for rapid reduction in hepatic glucose output after meal ingestion. Recently was shown that the enhanced early (30-min) insulin secretion after morning meal vs. afternoon, was accompanied by a correspondingly faster incretin total GLP-1 and intact GLP-1 hormone response in the morning specially during the first 30 min after ingestion. The association was consistent and also supports the prediction that higher GLP-1 levels after morning meal would result in a higher potentiation of β-cell function. This diurnal pattern of enhanced insulin and GLP-1 response after morning meal versus in the evening, might be underlying explanation of the beneficial effect of eating breakfast with reduced dinner vs skipping breakfast on glycemic control and HbA1c in T2D patients. To test this hypothesis the investigators will compare in random order and in two separate days: the glucose, insulin and GLP-1 postprandial responses after breakfast, lunch and dinner with 2 isocaloric meal plans or test diets, that differ only in meal timing distribution 1. High caloric breakfast, average lunch and reduced dinner (BTdiet) and 2. High caloric dinner, similar lunch and reduced breakfast (DTdiet)

Interventions

OTHERHigh Calorie Breakfast (BTdiet)

High Caloric Breakfast Test Diet (BTdiet): in which the majority of energy load will be consumed in the morning and with reduced dinner

OTHERHigh Caloric Dinner (DTdiet)

High Caloric Dinner (DTdiet): resembling a skipping breakfast plan, in which the majority of energy load will be consumed in the evening with minimal caloric content at breakfast

Sponsors

Wolfson Medical Center
CollaboratorOTHER_GOV
Tel Aviv University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

1. Type 2 diabetes patients 2. HbA1C \> 7% 3. Duration of diabetes: 0.5 to 10 years 4. Subjects ≥ 30 and ≤70 years of age 5. BMI: 22 to 35 kg/m2 6. Diet controlled diabetic. Only treatment with metformin will be allowed 7. Normal liver and kidney function 8. Normal thyroid function 9. Acceptable health beside diabetes based on interview, medical history, physical examination, and laboratory tests 10. Stable physical activity pattern during the three months immediately preceding study 11. Usually wakes up between 06:00 and 07:00 and goes to sleep between 22:00 and 24:00. 12. No shift work within 5 years of the study 13. Did not cross time zones within 1 month of the study 14. Read and understood the informed consent form and signed it voluntarily

Exclusion criteria

1. Type 1 diabetes 2. Clinically significant pulmonary, cardiac, renal, hepatic, neurologic, psychiatric, infectious, malignant disease 3. Abnormal liver function tests defined as an increase by a factor of at least 2 above the upper normal limit of alanine aminotransferase (ALT) and/or aspartate aminotransferase (AST) 4. Pregnancy or lactation 5. Illicit drug abuse or alcoholism 6. Treatment with antidiabetic drugs, insulin or GLP-1 analogs 7. Subjects taking anoretic drugs during the month immediately prior to study 8. Subjects on steroid treatment 9. Those with eating disorders 10. Subjects after bariatric surgery, will be excluded

Design outcomes

Primary

MeasureTime frameDescription
Postprandial GLP-1 plasma levels, after breakfast,lunch and dinner meal testDuring 3 hours after breakfast, lunch and dinner meal challangeAll Type 2 diabetic participants will be randomly assigned to one of 2 isocaloric diet sequences that will differ in the meal timing distribution. The diets will be tested in two separate occasions during a curse of a single day (test day) in which postprandial plasma GLP-1 levels during 3 hours after breakfast, lunch and dinner meal challenge will be measured

Secondary

MeasureTime frameDescription
Postprandial Plasma Glucose levels after breakfast, lunch and dinner meal challengePostprandial Plasma Glucose levels during 3 hours after breakfast, lunch and dinner meal challengeAll Type 2 diabetic participants will be randomly assigned to one of 2 isocaloric diet sequences that will differ in the meal timing distribution. The diets will be tested in two separate occasions during a curse of a single day (test day) in which postprandial plasma Glucose levels during 3 hours after breakfast, lunch and dinner meal challenge will be measured

Other

MeasureTime frameDescription
Postprandial Insulin plasma levels, after breakfast,lunch and dinner meal testDuring 3 hours, after breakfast,lunch and dinner meal testAll Type 2 diabetic participants will be randomly assigned to one of 2 isocaloric diet sequences that will differ in the meal timing distribution. The diets will be tested in two separate occasions during a curse of a single day (test day) in which postprandial plasma Insulin levels during 3 hours after breakfast, lunch and dinner meal challenge will be measured

Countries

Israel

Contacts

Primary ContactDaniela Jakubowicz, MD
daniela.jak@gmail.com972508105552
Backup ContactJulio Wainstein, MD
vainstein@wolfson.health.gov.il972545722296

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 18, 2026